Related Experiment Video
Updated: Mar 15, 2026
10:13
Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding
Published on: June 9, 2017
17.4K
GRK2 Constitutively Governs Peripheral Delta Opioid Receptor Activity
Allison Doyle Brackley1, Ruben Gomez2, Armen N Akopian3
1Department of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA.
Cell Reports
|August 30, 2016
Summary
Peripheral delta-opioid receptors (DOR) are key for pain relief but are often inactive. G protein-coupled receptor kinase 2 (GRK2) inhibits DOR activity, but bradykinin can restore DOR function for novel pain management strategies.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Opioids are standard analgesics, but systemic side effects limit long-term use.
- Delta-opioid receptors (DOR) offer analgesic potential, especially peripherally restricted agents.
- DOR require specific conditions to be effective for pain relief.
Purpose of the Study:
- To investigate the mechanism inhibiting peripheral delta-opioid receptor (DOR) analgesic efficacy.
- To identify molecular players regulating DOR activity in sensory neurons.
- To explore how inflammatory mediators restore DOR function.
Main Methods:
- Co-immunoprecipitation assays to study protein interactions.
- Confocal microscopy to visualize protein localization.
- Pharmacological activation of receptors and signaling pathways.
Main Results:
- G protein-coupled receptor kinase 2 (GRK2) directly binds to and inhibits peripheral DOR.
- GRK2 binding prevents Gβ subunit association, reducing DOR signaling.
- Bradykinin triggers GRK2 translocation from DOR to RKIP, restoring DOR activity.
- PKC-dependent RKIP phosphorylation sequesters GRK2, enabling DOR function.
Conclusions:
- GRK2 acts as a negative regulator of peripheral DOR analgesic efficacy.
- Bradykinin-induced GRK2 sequestration is a novel mechanism for restoring DOR function.
- This study reveals a non-internalizing role for GRK2 in maintaining peripheral analgesia incompetence.
Related Concept Videos
01:22Opioid Receptors: Overview
6.0K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
6.0K
01:12GPCR Desensitization
8.5K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
8.5K
01:09GPCRs Regulate Adenylyl Cylase Activity
8.0K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
8.0K
01:29The Two-State Receptor Model
3.4K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
3.4K
01:25Analgesia and Pain Management
2.7K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.7K
01:30Transducer Mechanism: G Protein–Coupled Receptors
6.8K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
6.8K